Elpamotide is an epitope peptide derived from VEGFR2. Elpamotide induces cytotoxic T lymphocytes (CTLs) to kill VEGFR2-expressing endothelial cells. Elpamotide has potential immunostimulatory and antineoplastic activities. Elpamotide can be used in the r
Molecular Weight:
1073.21
CAS Number:
[673478-49-4]
Formula:
C47H76N16O13
Target:
Others
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted